BCR-AblSilencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy

2019 ◽  
Vol 28 (11) ◽  
pp. 734-744 ◽  
Author(s):  
Remant KC ◽  
Bindu Thapa ◽  
Anyeld Ubeda ◽  
Xiaoyan Jiang ◽  
Hasan Uludağ
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Leukemia Cells ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Leukemia ◽  
2019 ◽  
Vol 33 (8) ◽  
pp. 2116-2120 ◽  
Author(s):  
L. Janssen ◽  
S. J. C. M. Frambach ◽  
N. A. E. Allard ◽  
M. T. E. Hopman ◽  
T. J. J. Schirris ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Tyrosine Kinase Inhibitor Therapy ◽  
Muscle Toxicity
Sign in / Sign up

Export Citation Format

Share Document